Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-16

Clinical Trial Update: Nitrous Oxide for the Treatment of Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitrous oxide for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Bayside Health | Conditions: Depression, Major Depressive Disorder | Phase 2 | Status: COMPLETED